← Leaderboards
Steven R Schwid
University Of Rochester
$44,977
Attributed
$44,977
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$44,977 · 4
By mechanism
M01$44,977 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- Roger M Kurlan$13,810,390
- Benjamin Matthew Segal$9,506,634
- B. Paige Lawrence$23,471,485
- Irene H Richard$4,554,718
- Gretchen Lano Birbeck$12,919,100
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectMultiple SclerosisHuman Therapy EvaluationDiagnosis Design /EvaluationClinical TrialsDiagnosis Quality /StandardFunctional AbilityGaitInduced HypothermiaImmunopathology TherapyCold TemperaturePerformanceNervous System Disorder TherapyPharmacokineticsAntiparkinson DrugsRelapse /RecurrenceBlood ChemistryCombination ChemotherapyDihydroxyphenylalanineDrug Adverse EffectDrug InteractionsFatigueImmunopathology Chemotherapy
Grant awards (8)
THE EFFECTS OF AVONEX ON FATIGUE COMPONENTS IN MULTIPLE SCLEROSIS;A PILOT STUDY$530
M01 · FY2005 · RR
The Effects of Avonex on Fatigue Components in MS$5,221
M01 · FY2004 · RR
VALIDATING MEASURES OF AMBULATORY IMPAIRMENT FOR MULTIPLE SCLEROSIS CLINICAL TRL$0
M01 · FY2002 · RR
EVALUATION OF COOLING THERAPY FOR MULTIPLE SCLEROSIS$0
M01 · FY2002 · RR
PHARMACOKINETIC INTERACTIONS BETWEEN REMACEMIDE AND LEVODOPA IN PD$19,613
M01 · FY2001 · RR
VALIDATING MEASURES OF AMBULATORY IMPAIRMENT FOR MULTIPLE SCLEROSIS CLINICAL TRL$19,613
M01 · FY2001 · RR
VALIDATING MEASURES OF AMBULATORY IMPAIRMENT FOR MULTIPLE SCLEROSIS CLINICAL TRL$0
M01 · FY2000 · RR
EVALUATION OF COOLING THERAPY FOR MULTIPLE SCLEROSIS$0
M01 · FY2000 · RR